MedTrace Logo

Safety and Economics of Parenchymal Transection in Minimally Invasive Liver Surgery

NCT07750275 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2026-08-06

No results posted yet for this study

Summary

LIVER-MIND 2 is a multicentre, observational, retrospective registry coordinated by the SICE HPB and Minimally Invasive Surgery Working Group, enrolling consecutive adults undergoing elective minimally invasive (laparoscopic, robotic or hybrid) liver resection between January 2021 and December 2025 across ≥15 high-volume or dedicated centres (target \>30 centres).

Conditions

  • Liver Surgery
  • MINIMALLY INVASIVE LIVER SURGERY
  • Liver Neoplasm

Sponsors & Collaborators

  • University of Molise

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2026-12-31
Completion
2027-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07750275 on ClinicalTrials.gov